BASILEA PHARMACEUTICA INTERNATIONAL LTD.

BASILEA PHARMACEUTICA

Chemical substances for use in the manufacture of pharmaceutical preparations for the treatment of dermatological conditions, the treatment of infections and diseases and in the research and development of pharmaceuticals in the treatment of dermatological conditions, the treatment of infections and diseases; diagnostic preparations for scientific clinical use; diagnostic reagents for clinical or medical laboratory use (Class 001); Pharmaceutical and veterinary products and preparations for the treatment and prevention of dermatological conditions, namely, eczema, inflammation, infection, warts, psoriasis, aging of the skin, ultra violet radiation and cancer; Veterinary products and preparations for the treatment and prevention of infections caused by bacteria, and Pharmaceutical and veterinary products and preparations for the treatment and prevention of infections caused by fungi, viruses, and rheumatoid arthritis; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of oncology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of gastroenterology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of neurology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of gynecology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of urology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of cardiology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of endocrinology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of nephrology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of hematology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of allergy; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of immunology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of psychiatry; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of anesthesiology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of rheumatology; diagnostic preparations for medical clinical purposes; clinical medical reagents;Chemical substances for use in the manufacture of pharmaceutical preparations for the treatment of dermatological conditions, the treatment of infections and diseases and in the research and development of pharmaceuticals in the treatment of dermatological conditions, the treatment of infections and diseases; diagnostic preparations for scientific clinical use; diagnostic reagents for clinical or medical laboratory use;PHARMACEUTICA;Research and development services for third parties in the field of chemical substances, pharmaceutical and veterinary products and preparations;

BASILEA PHARMACEUTICA

Pharmaceutical products and preparations for the treatment and prevention of infections caused by bacteria;PHARMACEUTICA;

BASILEA PHARMACEUTICA

Pharmaceutical and veterinary products and preparations for the treatment and prevention of dermatological conditions, namely, eczema, inflammation, infection, warts, psoriasis, aging of the skin, ultra violet radiation and cancer; Pharmaceutical and veterinary products and preparations for the treatment and prevention of infections caused by bacteria, fungi, viruses, and rheumatoid arthritis; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of oncology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of gastroenterology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of neurology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of gynecology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of urology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of cardiology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of endocrinology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of nephrology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of hematology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of allergy; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of immunology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of psychiatry; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of anesthesiology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of rheumatology; diagnostic preparations for medical purposes; clinical medical reagents;Chemical substances for use in the manufacture of pharmaceutical preparations for the treatment of dermatological conditions, the treatment of infections and diseases and in the research and development of pharmaceuticals in the treatment of dermatological conditions, the treatment of infections and diseases; diagnostic preparations for scientific clinical use; diagnostic reagents for clinical or medical laboratory use;PHARMACEUTICA;Research and development services for third parties in the field of chemical substances, pharmaceutical and veterinary products and preparations;

ZEFTERA

human pharmaceutical preparations, namely, anti-infectives;

ZEFTERA

Human pharmaceutical preparations, namely, anti-infectives, excluding ophthalmic pharmaceuticals;

ZEFTERA

Human pharmaceutical preparations, namely, anti-infectives;

ZEFTERA

Human pharmaceutical preparations, namely, anti-infectives;

ZEFTERA

Human pharmaceutical preparations, namely, anti-infectives;

ZEVTERA

human pharmaceuticals, namely, anti-infectives;

ZEVTERA

Human pharmaceuticals for the treatment of infectious-related diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases and pain, dermatologic disorders, hemostatic agents, metabolic diseases, anti-viral diseases, oncologic diseases, and respiratory diseases, muscle dystonias, wrinkles and smooth muscle disorders, gastro-intestinal diseases, excluding ophthalmic diseases;

ZEVTERA

Pharmaceutical preparations and substances for the treatment of infectious diseases, dermatological disorders, oncological diseases, gastrointestinal diseases, neurological diseases, cardiovascular diseases, and gynecological diseases;

ZEVTERA

Pharmaceutical preparations and substances for the treatment of infectious diseases, dermatological disorders, oncological diseases, gastrointestinal diseases, neurological diseases, cardiovascular diseases, and gynecological diseases;

ZEVTERA

Pharmaceutical preparations and substances for the treatment of infectious diseases, dermatological disorders, oncological diseases, gastrointestinal diseases, cardiovascular diseases, gynecological diseases, and autoimmune diseases;

ZEVTERA

Pharmaceutical preparations and substances for the treatment of infectious diseases, dermatological disorders, oncological diseases, gastrointestinal diseases, neurological diseases, cardiovascular diseases, gynecological diseases, and autoimmune diseases;